Before widespread prostate cancer screening began in the late 1980s, many men newly diagnosed with the disease had advanced cancer that had spread beyond the prostate. Today, in the screening era, most men with the disease are diagnosed when their cancer is in an earlier, more curable stage. But, even
The term prostatitis describes inflammation of the prostate gland. Unlike other prostatic conditions, prostatitis affects younger and older men alike. It is common, affecting up to 1 in 12 men in their lifetime and keeping urologists busy (it’s responsible for 25 percent of all visits to urology clinics).
In the United
There is an expression in medicine that “common things are common,” and benign prostatic hyperplasia is most certainly common, affecting more than 50 percent of men in their 60s and up to 90 percent of men in their 80s. BPH is a non-cancerous enlargement of the prostate gland due to
Prostate cancer is the second-most-common cancer in men (after skin cancer) and the second-most-common cause of cancer-related death in men (after lung cancer). Latest data from the American Cancer Society: One in nine men will be diagnosed with prostate cancer in their lifetime, and one in 41 will die from
Hidden deep within the male pelvis is a small gland about the size of a walnut known as the prostate. The prostate is an essential part of the male reproductive system. But it suffers from a serious design flaw.
Similar to a rubber ring, the prostate surrounds the urethra, the thin,
It’s well known that the prostate-specific antigen (PSA) test used to screen for prostate cancer is imprecise. Elevations in PSA may signal prostate cancer, but they also may be due to nonmalignant prostate conditions.
Further complicating the screening process is that several medications and a number of other modifiable factors may
Other than the fact that prostate-specific antigen (PSA) screening is a simple blood test, little else about this cornerstone of prostate cancer screening is simple. That includes the question of whether there are normal PSA levels by age. Generally, your risk of having prostate cancer increases along with your PSA
Recent data (Cancer, May 22) points to a rise in the diagnosis of late-stage prostate cancer. In the study, diagnoses in which the cancer had already spread to other parts of the body increased from 7.8 per 100,000 in 2010 to 9.2 per 100,000 in 2014.
Reza Mehrazin, MD, assistant professor
Prostate Cancer Screening Has Minimal Effect on Mortality
Prostate cancer screening using the prostate-specific antigen (PSA) blood test has no effect on overall mortality, according to a systematic review and meta-analysis published in BMJ in September. Furthermore, the screening is associated with biopsy-related and cancer treatment–related complications that include sepsis, urinary
More than two-thirds of people age 70 and older have clinically meaningful hearing loss, and the effects can be much more significant than having to strain to hear the television or radio. Not being able to hear well can affect your ability to socialize with family and friends, and lead